Cytochrome P4501A1 and Glutathione S-Transferase M1 Genotypes as Risk Factors for Prostate Cancer in Japan

Japanese Journal of Clinical Oncology

Volumn 28, Issue 11, 1998, Pages 657-660

  Murata, Mariko ^a   Shiraishi, Taizo ^a   Fukutome, Kazuo ^a   Watanabe, Masatoshi ^a   Nagao, Minako ^b   Kubota, Yoshinobu ^c   Ito, Haruo ^d   Kawamura, Juichi ^a   Yatani, Ryuichi ^a  

^a MIE UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Cytochrome P4501A1; Genetic polymorphisms; Glutathione S transferase M1; Prostate cancer

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE;

AGED; ARTICLE; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; PROSTATE TUMOR; RISK FACTOR;

AGED; AGED, 80 AND OVER; CYTOCHROME P-450 CYP1A1; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0032215464     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.11.657     Document Type: Article

References (31)

1. Dijkman GA, Debruyne FM Epidemiology of prostate cancer. European Urol 1996;30:281-95.
2. Hsing AW, Devesa SS. Prostate cancer mortality in the United States by cohort year of birth, 1865-1940. Cancer Epidem Biomar 1994;3:527-30.
3. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6.
4. Tsugane S, Costa MJ, Mirra AP, Gotlieb SL, Laurenti R, Watanabe S. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil. 1969-78. Cancer Cause Control 1990;1:189-93.
5. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
6. Watanabe M, Fukutome K, Shiraishi T, Murata M, Kawamura J, Yatani R et al. Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries. Carcinogenesis 1997;18:1355-8.
7. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993;118:793-803.
8. van der Gulden JW, Verbeek AL, Kolk JJ. Smoking and drinking habits in relation to prostate cancer. Br J Urol 1994;73:382-9.
9. Shirai T, Sano M, Tamano S, Takahashi S, Sugimura T, Ito N. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997;57:195-8.
10. Japanese Urological Association and the Japanese Pathological Society. General Rule for Clinical and Pathological Studies on Prostatic Cancer, 2nd edn. Kanehara Press, Tokyo, 1992.
11. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 1991;19:4797.
12. Hirvonen A, Husgafvel PK, Karjalainen A, Anttila S, Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidem Biomar 1992;1:485-9.
13. Comstock KE, Sanderson BJ, Claflin G, Henner WD. GSTI gene deletion determined by polymerase chain reaction. Nucleic Acids Res 1990;18:3670.
14. Groppi A, Coutelle C, Fleury B, Iron A, Begueret J, Couzigou P. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum Genet 1991;87:628-30.
15. Kawajiri K, Fujii KY. P450 and human cancer Jpn J Cancer Res 1991;82:1325-35.
16. Raunio H, Husgafvel PK, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 1995;159:113-21.
17. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 1991;110:407-11.
18. Oyama T, Mitsudomi T, Kawamoto T, Osaki T, Kodama Y, Yasumoto K. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occ Env Health 1995;67:253-6.
19. Crofts F, Taioli E, Trachman J, Currie D, Toniolo P, Garte SJ Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994;15:2961-3.
20. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993.53:2994-9.
21. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Michalek AM, Harrington A. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995;55:3483-5.
22. Rosenberg DW, Leff T. Regulation of cytochrome P450 in cultured human colonic cells. Arch Biochem Biophys 1993;300:186-92.
23. Mannervik B, Danielson UH. Glutathione transferases - structure and catalytic activity. Crit Rev Biochem 1988;23:283-337.
24. Brockmoller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994;54:4103-11.
25. Bell DA, Thompson CL, Taylor J, Perera F, Hsieh LL, Lucier GW Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Persp 1992;98:113-7.
26. Hirvonen A, Nylund L, Kociba P, Husgafvel PK, Vainio H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 1994;15:813-5.
27. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase Ml (GSTM1) that increases susceptibility to bladder cancer J Natl Cancer Inst 1993;85:1159-64.
28. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analysed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 1992;83:866-70
29. Hirvonen A, Husgafvel PK, Anttila S, Vainio H. The GSTMI null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14:1479-81.
30. Katoh T, Inatomt H, Nagaoka A, Sugita A Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis 1995;16:655-7.
31. Hammons GJ, Milton D, Stepps K, Guengench FP, Tukey RH, Kadlubar FF. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis 1997;18:851-4.